OncoLens

Atlanta, United States

OncoLens replaces the current labor intensive process of patient case collaboration and subsequent CoC accreditation in cancer care.

$16.0M raised

Oct 2024

Series B

Top Investors

SeedToB CapitalBIP CapitalCross-Border Impact VenturesMartin VenturesAtlanta Technology Angels

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has OncoLens raised?

OncoLens has raised $16.0M in total funding. The most recent round was Series B. The last funding was announced in October 2024.

Who are OncoLens's investors?

OncoLens's investors include SeedToB Capital, BIP Capital, Cross-Border Impact Ventures, Martin Ventures, Atlanta Technology Angels.

Where is OncoLens headquartered?

OncoLens is headquartered in Atlanta, United States.

What does OncoLens do?

OncoLens replaces the current labor intensive process of patient case collaboration and subsequent CoC accreditation in cancer care.

What stage is OncoLens at?

OncoLens is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 24, 2024.

MLA

"OncoLens — Funding & Investors." VCBacked, October 24, 2024, https://www.vcbacked.co/company/oncolens. Accessed June 17, 2026.

APA

VCBacked. (2024). OncoLens — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/oncolens

Wikipedia (cite web)

{{cite web |title=OncoLens — Funding & Investors |url=https://www.vcbacked.co/company/oncolens |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 24, 2024.